Cambridge, MA, United States of America

Amael Madec

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amael Madec: Innovator in Cancer Therapeutics

Introduction

Amael Madec is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of cancer therapeutics. His innovative work focuses on the development of compounds that activate the aryl hydrocarbon receptor (AHR) for the treatment of various cancers. With a patent portfolio that includes a groundbreaking approach to cancer treatment, Madec is at the forefront of medical research.

Latest Patents

Amael Madec holds a patent for "Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics." This patent outlines compositions and methods for diagnosing and treating cancers, particularly those with elevated expression of FOXA1 and its gene targets. The patent specifically addresses certain types of breast, liver, and prostate cancers, including luminal and ER-positive forms of breast cancer. The disclosed methods involve the use of adenosine receptor antagonists, such as CGS-15943, MRS-1220, and SCH-58261, which are shown to kill cancer cells by activating the AHR. This innovative approach provides new therapeutic options for patients at risk of developing cancer.

Career Highlights

Throughout his career, Amael Madec has worked with prestigious organizations, including the Broad Institute and Dana-Farber Cancer Institute. His experience in these leading research institutions has allowed him to collaborate with some of the brightest minds in the field of cancer research. His work has not only advanced scientific understanding but has also paved the way for new treatment methodologies.

Collaborations

Amael Madec has collaborated with notable colleagues, including Steven Corsello and Ryan Spangler. These partnerships have contributed to the development of innovative cancer therapies and have enhanced the research landscape in which he operates.

Conclusion

Amael Madec's contributions to cancer therapeutics through his innovative patent and collaborations with leading research institutions highlight his role as a significant figure in the fight against cancer. His work continues to inspire advancements in medical research and treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…